PURPOSE: We investigated the qualitative distribution of vitamin D receptor in human testis pathologies and performed an in vitro study of vitamin D receptor expression in a human testis cancer cell line model. MATERIALS AND METHODS: Qualitative immunohistochemical analysis of vitamin D receptor in testis tumors, normal testis and specimens from infertile patients was performed. The human embryonal carcinoma cell line NT2/D1 (American Type Culture Collection, Manassas, Virginia) was cultured. Vitamin D receptor expression was examined by Western immunoblot analysis after incubating the cells with 250 to 800 nM vitamin D, 10 to 70 nM testosterone, 2 nM calcium or a combination of the 3 products. RESULTS: Negative controls, synctiotrophoblasts and interstitial stroma did not stain positive for vitamin D receptor. Spermatogenic, Sertoli's, Leydig and tumor cells stained positive in all specimens. Embryonal carcinoma demonstrated more nuclear and cytoplasmic staining than other tumors. Vitamin D receptor expression was seen at 50 kDa in the cell line. Sequential concentrations of vitamin D increased vitamin D receptor expression intensity. Simultaneous addition of vitamin D and testosterone decreased the vitamin D receptor signal, as did testosterone alone. Delayed administration of vitamin D 5 hours after testosterone showed the return of vitamin D receptor expression. A combination of calcium, testosterone and vitamin D showed decreased or no vitamin D receptor expression. Calcium alone increased vitamin D receptor expression at later passages. CONCLUSIONS: To our knowledge this is the first description of vitamin D receptor in different primary testis pathologies and in an embryonal carcinoma cell line. The in vitro model showed that vitamin D receptor is an active receptor and it is inducible with the addition of vitamin D. Testosterone may be important for vitamin D receptor down-regulation. Calcium may be an important co-factor in vitamin D receptor expression.
PURPOSE: We investigated the qualitative distribution of vitamin D receptor in human testis pathologies and performed an in vitro study of vitamin D receptor expression in a humantestis cancer cell line model. MATERIALS AND METHODS: Qualitative immunohistochemical analysis of vitamin D receptor in testis tumors, normal testis and specimens from infertilepatients was performed. The humanembryonal carcinoma cell line NT2/D1 (American Type Culture Collection, Manassas, Virginia) was cultured. Vitamin D receptor expression was examined by Western immunoblot analysis after incubating the cells with 250 to 800 nM vitamin D, 10 to 70 nM testosterone, 2 nM calcium or a combination of the 3 products. RESULTS: Negative controls, synctiotrophoblasts and interstitial stroma did not stain positive for vitamin D receptor. Spermatogenic, Sertoli's, Leydig and tumor cells stained positive in all specimens. Embryonal carcinoma demonstrated more nuclear and cytoplasmic staining than other tumors. Vitamin D receptor expression was seen at 50 kDa in the cell line. Sequential concentrations of vitamin D increased vitamin D receptor expression intensity. Simultaneous addition of vitamin D and testosterone decreased the vitamin D receptor signal, as did testosterone alone. Delayed administration of vitamin D 5 hours after testosterone showed the return of vitamin D receptor expression. A combination of calcium, testosterone and vitamin D showed decreased or no vitamin D receptor expression. Calcium alone increased vitamin D receptor expression at later passages. CONCLUSIONS: To our knowledge this is the first description of vitamin D receptor in different primary testis pathologies and in an embryonal carcinoma cell line. The in vitro model showed that vitamin D receptor is an active receptor and it is inducible with the addition of vitamin D. Testosterone may be important for vitamin D receptor down-regulation. Calcium may be an important co-factor in vitamin D receptor expression.
Authors: Martin Blomberg Jensen; Anne Jørgensen; John Erik Nielsen; Andreas Steinmeyer; Henrik Leffers; Anders Juul; Ewa Rajpert-De Meyts Journal: Neoplasia Date: 2012-10 Impact factor: 5.715
Authors: A Alzoubi; H Mahdi; S Al Bashir; O Halalsheh; M Al Ebbini; M Alzarir; K Al-Ahmar; M Alfaqih; A H Al-Hadidi Journal: Acta Endocrinol (Buchar) Date: 2017 Apr-Jun Impact factor: 0.877
Authors: S Vladoiu; A Botezatu; G Anton; D Manda; D L Paun; S Oros; R Rosca; D Dinu Draganescu Journal: Acta Endocrinol (Buchar) Date: 2017 Jul-Sep Impact factor: 0.877
Authors: Massimo Tartagni; Maria Matteo; Domenico Baldini; Mario V Tartagni; Hala Alrasheed; Maria A De Salvia; Giuseppe Loverro; Monica Montagnani Journal: Reprod Biol Endocrinol Date: 2015-11-21 Impact factor: 5.211